Finance

Beta
Lists
4369:TYO
Tri Chemical Laboratories Inc
Â¥3,500.00
-4.89%
(-180.00) 1D
Jun 24, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4369...
Open
Â¥3,610
High
Â¥3,725
Low
Â¥3,430
Mkt. cap
113.75B
Avg. vol.
803.50K
Volume
530.70K
P/E ratio
18.46
52-wk high
Â¥4,455
52-wk low
Â¥2,455
EPS
Â¥190
Shares outstanding
7.81M
No. of employees
313
Open
Â¥3,610
High
Â¥3,725
Low
Â¥3,430
Mkt. cap
113.75B
Avg. vol.
803.50K
Volume
530.70K
P/E ratio
18.46
52-wk high
Â¥4,455
52-wk low
Â¥2,455
EPS
Â¥190
Shares outstanding
7.81M
No. of employees
313
News stories
From sources across the web
About Tri Chemical Laboratories Inc
CEO-
Employees313
FoundedDec 6, 1978
Headquarters-
SectorSemiconductor
Last report
May 29, 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
7.49B / 6.90B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
5.81B
5.64B
5.87B
7.49B
Cost of goods sold
3.57B
3.49B
3.71B
4.69B
Cost of revenue
3.57B
3.49B
3.71B
4.69B
Research and development expenses
-
-
606.00M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
766.05M
758.51M
131.52M
730.52M
Operating expense
766.05M
758.51M
817.52M
730.52M
Total operating expenses
4.34B
4.25B
4.53B
5.42B
Operating income
1.47B
1.38B
1.34B
2.07B
Other non operating income
7.49M
-36.17M
-43.75M
-1.55M
EBT including unusual items
2.16B
1.66B
1.63B
2.49B
EBT excluding unusual items
2.16B
1.66B
1.63B
2.49B
Income tax expense
590.53M
413.68M
137.00M
630.03M
Effective tax rate
27.35%
24.94%
8.40%
25.35%
Other operating expenses
-
-
-
-
Net income
1.57B
1.24B
1.49B
1.86B
Net profit margin
27.02%
22.09%
25.43%
24.78%
Earnings per share
-
-
-
-
Interest and investment income
665.00K
6.48M
426.00K
3.83M
Interest expense
-5.79M
-6.82M
-14.56M
-22.60M
Net interest expenses
-5.12M
-340.00K
-14.13M
-18.77M
Depreciation and amortization charges
-
-
80.00M
-
EBITDA
1.91B
1.86B
1.92B
2.67B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more